ANVISA has approved the update of the 2024-2025 Regulatory Agenda, which defines the priorities for the period, guiding the regulation in sectors that are critical to public health. Among the updated topics are standards for medical devices, medicines, food, and initiatives related to health safety and technological innovation. This agenda aims to align regulatory efforts with market demands and society's needs, with a focus on transparency and predictability for companies.
For the electromedical products sector, certified in accordance with specific requirements, the update of the agenda does not foresee direct changes that impact the certification criteria already in force. However, Anvisa highlighted the intention to review standards to incorporate technological advances and align national provisions with international best practices. This may bring new opportunities for the development of safer and more innovative solutions, in addition to strengthening the competitiveness of Brazilian industry in the global market.
The Regulatory Agenda also prioritizes the debureaucratization of processes and the strengthening of the dialogue between Anvisa and the regulated sectors, ensuring greater efficiency and safety in the monitoring of products in circulation on the market. For manufacturers and companies operating in the medical device sector, it is essential to follow these updates, ensuring compliance with future requirements.
For more information on the updates and the next steps of the agenda, access the full article from Anvisa: Click here https://lnkd.in/eQdHrKBd.
Read the full article: https://www.linkedin.com/posts/pcn-latin-america_anvisa-regulaaexaeto-produtoseletromaezdicos-activity-7269882377231880192-FI72?utm_source=share&utm_medium=member_desktop
